Edurne García Vidal

Investigador/a postdoctoral

Grup de recerca

Equip

Edurne Garcia es va graduar en Bioquímica per la Universitat Autònoma de Barcelona l’any 2013 i va continuar els seus estudis a la Universitat de Barcelona, on va completar el màster en Genètica i Genòmica el 2014. Durant els seus estudis, va realitzar pràctiques al laboratori clínic de l’Hospital Universitari Dr. Josep Trueta de Girona i va elaborar el seu projecte de màster al Centre de Regulació Genòmica (CRG) de Barcelona. El 2015 va treballar al Banc de Germoplasma ISOPlexis a Portugal i el 2016 va iniciar els seus estudis de doctorat a IrsiCaixa.

Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection.

Revista

International journal of molecular sciences

Any

2022
IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation.

Revista

Frontiers in immunology

Any

2022
CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.

Revista

Nature communications

Any

2018
RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages.

Revista

Scientific reports

Any

2017
Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir.

Revista

Antimicrobial agents and chemotherapy

Any

2017

Veure totes les publicacions

Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection.

IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation.

CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.

RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages.

Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir.